1015 Walnut Street
613 Curtis Building
Philadelphia, PA 19107
(215) 955-1410
(215) 923-7885 fax
613 Curtis Building
Philadelphia, PA 19107
(215) 955-1410
(215) 923-7885 fax
Most Recent Peer-reviewed Publications
- Predictors of early mortality in systemic sclerosis: A case-control study comparing early versus late mortality in systemic sclerosis
- Management of gastrointestinal manifestations in systemic sclerosis (scleroderma)
- Interstitial lung disease in systemic sclerosis: Pathophysiology, current and new advances in therapy
- Initial presentation of acute transverse myelitis in systemic lupus erythematosus: Demographics, diagnosis, management and comparison to idiopathic cases
- Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: Results from the PHAROS registry< 1874 /li>
- Diagnosis and management of systemic sclerosis
- Gastric antral vascular ectasia in systemic sclerosis
- Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study.
- Disease-modifying drugs for systemic sclerosis: Why have we not found them yet?
- Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi consensus study from EULAR scleroderma trials and research group
- Endothelin receptor antagonists as disease modifiers in systemic sclerosis
- Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
- Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis: Reply
- Eosinophilic fasciitis in a pediatric patient
- Gastric Antral Vascular Ectasia in Systemic Sclerosis: Demographics and Disease Predictors
- Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
- Advances in disease-specific treatment of systemic sclerosis
- A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
- Systemic sclerosis at the cellular level: Molecular pathways of pathogenesis and its implication on future drug design
- The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: A retrospective study and literature review